D-CAL

Dosage form: tablet, chewable
Ingredients: CALCIUM CARBONATE 750mg
Labeler: A&Z Pharmaceutical Inc.
NDC code: 62211-166

Medically reviewed by Drugs.com. Last updated on Sep 23, 2024.

D-CAL (calcium carbonate ) tablet, chewable

Active ingredient (in each tablet)

Calcium Carbonate 750 mg

Purpose

Antacid

Uses

relieves

heartburn
acid indigestion
sour stomach
upset stomach due to these symptoms

Warnings

Ask a doctor or pharmacist before use if you are taking a prescription drug. Antacids may interact with certain prescription drugs.

When using this product

do not take more than 10 tablets for adults and 5 tablets for children in a 24 hour period.

Keep out of reach of children.

Directions

Adults: chew 2 tablets daily.
Children: chew 1 tablet daily. If symptoms persist, ask a doctor.

Other information

Store in a dry place
do not use if imprinted seal under cap is torn or open

Inactive ingredients

Cholecalciferol, D&C red #27, flavors, magnesium stearate, sorbitol

PRINCIPAL DISPLAY PANEL

D-CAL
calcium carbonate tablet, chewable

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC:62211-166
Route of Administration	ORAL	DEA Schedule

Active Ingredient/Active Moiety
Ingredient Name	Basis of Strength	Strength
CALCIUM CARBONATE (CALCIUM CATION)	CALCIUM CARBONATE	750 mg

Inactive Ingredients
Ingredient Name	Strength
CHOLECALCIFEROL
D&C RED NO. 27
MAGNESIUM STEARATE
SORBITOL

Product Characteristics
Color	pink	Score	no score
Shape	RECTANGLE	Size	17mm
Flavor	TROPICAL FRUIT PUNCH	Imprint Code	DCAL;AZ
Contains

Packaging
#	Item Code	Package Description
1	NDC:62211-166-60	60 TABLET, CHEWABLE in 1 BOTTLE

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
OTC monograph final	part331	09/17/1997

Labeler - A&Z Pharmaceutical Inc. (080225262)

Registrant - A&Z Pharmaceutical Inc. (080225262)

Establishment
Name	Address	ID/FEI	Operations
A&Z Pharmaceutical Inc.		080225262	manufacture(62211-166)

Revised: 10/2019

Document Id: 9402dcf7-ebbc-feee-e053-2995a90af2a8

Set id: 303bee24-d308-4b16-b382-c5f818014117

Version: 7

Effective Time: 20191003

A&Z Pharmaceutical Inc.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer

D-CAL

Further information

See also:

Qulipta

Aimovig

Dupixent

Ubrelvy

Nurtec ODT

Xeomin

Dysport

Botox Cosmetic

Arazlo

Tazorac